Side-by-side comparison of AI visibility scores, market position, and capabilities
US YC W23 e-commerce AI support resolving 5M+ tickets for 100+ Shopify merchants at $3.3M revenue 2024; $5.75M Sequoia Series A Sep 2024 competing with Gorgias and Intercom for automated WISMO/returns/Q&A with performance-based pricing.
Yuma AI is a United States-based e-commerce customer support AI company — backed by Y Combinator (W23) with $5.75 million in total funding including a $5 million Series A in September 2024 led by Sequoia Capital with participation from Liquid 2 Ventures and Kima Ventures — providing online retailers (particularly Shopify merchants) with AI-powered customer support agents that autonomously resolve order inquiries, WISMO (Where Is My Order) requests, return and exchange processing, and customer Q&A without human agent intervention, generating $3.3 million in annual revenue in 2024 with a 22-person team and serving 100+ paying customers who have processed 5 million+ support tickets through Yuma's AI. Founded in 2023, Yuma has expanded beyond ticket resolution into performance-based pricing and a Shopify AI sales Q&A widget (launched September 2025).
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.